Simcere Pharmaceutical Group (NYSE:SCR)

CAPS Rating: 4 out of 5

The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.

Recs

0
Player Avatar manetheren86 (< 20) Submitted: 4/15/2009 12:30:37 PM : Outperform Start Price: $6.66 SCR Score: -29.92

On the rise...

Report this Post Reply

Featured Broker Partners


Advertisement